Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
Dhiren Singh1,2, Daniel W O’Connor11Department of Psychological Medicine, Monash University, Melbourne, Australia; 2Peninsula Mental Health Service, Melbourne, AustraliaAbstract: Antipsychotic medication is the mainstay of treatment in elderly patients with psychosis. In recent ye...
Saved in:
Main Authors: | Dhiren Singh, Daniel W O’Connor |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/ca15521c93e94e37a1ca3efe95168343 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Acting Injectable Drugs in the Maintenance Therapy of Patients with Schizophrenia
by: Natalia N. Petrova, et al.
Published: (2020) -
Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
by: Brasso C, et al.
Published: (2017) -
Risperidone for children and adolescents with autism spectrum disorder: a systematic review
by: Maneeton N, et al.
Published: (2018) -
Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate
by: Such P, et al.
Published: (2021) -
Attitudes and Willingness to Accept Long-Acting Injections for Patients With Schizophrenia in Beijing: A Cross-Sectional Investigation Based on Samples From the Communities
by: Junli Zhu, et al.
Published: (2021)